Letter: impact of HBV genotypes and PC/BCP mutations on serum HBsAg levels in Chinese HBeAg-negative patients

被引：0
|
作者：
Chen, E-Q. [1 ]
Wang, M-L. [1 ]
Wu, D-B. [1 ]
Liao, J. [1 ]
Tang, H. [1 ]
机构：
[1] Sichuan Univ, West China Hosp, Ctr Infect Dis, Chengdu, Sichuan, Peoples R China
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2018年 / 48卷 / 02期
关键词：
CHRONIC HEPATITIS-B;
D O I：
10.1111/apt.14815
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：236 / 237
页数：2
相关论文
共 50 条
  • [1] Letter: impact of HBV genotypes and PC/BCP mutations on serum HBsAg levels in Chinese HBeAg negative patients-Authors reply
    Kuhnhenn, L.
    Jiang, B.
    Kubesch, A.
    Zeuzem, S.
    Sarrazin, C.
    Hildt, E.
    Peffer, K-H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (02) : 238 - 239
  • [2] Impact of HBV genotype and mutations on HBV DNA and qHBsAg levels in patients with HBeAg-negative chronic HBV infection
    Kuhnhenn, L.
    Jiang, B.
    Kubesch, A.
    Vermehren, J.
    Knopf, V
    Susser, S.
    Dietz, J.
    Carra, G.
    Finkelmeier, F.
    Grammatikos, G.
    Zeuzem, S.
    Sarrazin, C.
    Hildt, E.
    Peiffer, K-H
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (11) : 1523 - 1535
  • [3] Editorial: HBsAg serum levels in HBeAg-negative chronic HBV infection-is it a matter of genotype?
    Alexopoulou, A.
    Karayiannis, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 102 - 103
  • [4] SERUM HBSAG LEVELS REFLECT INTRACELLULAR HBSAG, BUT NOT CCCDNA OR TOTAL LIVER HBV DNA IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B
    Manesis, Emanuel K.
    Papatheodoridis, George V.
    Tiniakos, Dina
    Hadziyannis, Emilia
    Agelopoulou, Olga P.
    Syminelaki, Thalia
    Papaioannou, Christos
    Nastos, Theodoros
    Karayannis, Peter
    HEPATOLOGY, 2009, 50 (04) : 969A - 970A
  • [5] Correlation Between HBsAg Quantitation and HBV DNA in HBeAg-Negative HBV/D Patients
    Teriaky, Anouar
    Al-Judaibi, Bandar
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2013, 19 (06): : 243 - 244
  • [6] Editorial: HBsAg serum levels in HBeAg-negative chronic HBV infection-is it a matter of genotype? Authors' reply
    Kuhnhenn, L.
    Jiang, B.
    Kubesch, A.
    Zeuzem, S.
    Sarrazin, C.
    Hildt, E.
    Peiffer, K. -H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (01) : 103 - 104
  • [7] Changes of serum HBsAg levels in HBeAg-negative chronic hepatitis B patients treated with tenofovir
    Papatheodoridis, George V.
    Triantos, Christos K.
    Hadziyannis, Emilia
    Zisimopoulos, Konstantinos
    Georgiou, Anastasia
    Margariti, Katerina
    Deutsch, Melanie
    Nikolopoulou, Vasiliki
    Manolakopoulos, Spilios
    HEPATOLOGY, 2013, 58 : 686A - 687A
  • [8] HBsAg and HBV DNA levels guiding entecavir cessation in HBeAg-negative chronic hepatitis B
    Seto, Wai-Kay
    Hui, Aric Josun
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    Liu, Kevin
    Lai, Ching-Lung
    Yuen, Man-Fung
    Chan, Henry Lik-Yuen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 414 - 414
  • [9] Pretreatment HBsAg serum levels predict HBsAg seroconversion in HBeAg-negative chronic hepatitis B (CHBe-) patients
    Manesis, EK
    Hadziyannis, ES
    Angelopoulou, OP
    Hadziyannis, SJ
    HEPATOLOGY, 2005, 42 (04) : 590A - 590A
  • [10] Serum ALT levels as a surrogate marker for serum HBV DNA levels in HBeAg-negative pregnant women
    Sangfelt, P
    Von Sydow, M
    Uhnoo, I
    Weiland, O
    Lindh, G
    Fischler, B
    Lindgren, S
    Reichard, O
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (03) : 182 - 185
12345